nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—migraine—Acetylsalicylic acid—coronary artery disease	0.471	1	CpDpCtD
Frovatriptan—HTR1B—Penbutolol—coronary artery disease	0.128	0.441	CbGbCtD
Frovatriptan—HTR1A—Penbutolol—coronary artery disease	0.0804	0.276	CbGbCtD
Frovatriptan—CYP1A2—Gemfibrozil—coronary artery disease	0.0358	0.123	CbGbCtD
Frovatriptan—CYP1A2—Clopidogrel—coronary artery disease	0.031	0.107	CbGbCtD
Frovatriptan—CYP1A2—Losartan—coronary artery disease	0.0152	0.0521	CbGbCtD
Frovatriptan—Hypersensitivity—Valsartan—coronary artery disease	6.84e-05	0.000397	CcSEcCtD
Frovatriptan—Convulsion—Ramipril—coronary artery disease	6.84e-05	0.000396	CcSEcCtD
Frovatriptan—Abdominal pain—Trandolapril—coronary artery disease	6.83e-05	0.000396	CcSEcCtD
Frovatriptan—Body temperature increased—Trandolapril—coronary artery disease	6.83e-05	0.000396	CcSEcCtD
Frovatriptan—Dizziness—Ezetimibe—coronary artery disease	6.82e-05	0.000395	CcSEcCtD
Frovatriptan—Palpitations—Timolol—coronary artery disease	6.82e-05	0.000395	CcSEcCtD
Frovatriptan—Abdominal pain—Enalapril—coronary artery disease	6.8e-05	0.000394	CcSEcCtD
Frovatriptan—Body temperature increased—Enalapril—coronary artery disease	6.8e-05	0.000394	CcSEcCtD
Frovatriptan—Feeling abnormal—Captopril—coronary artery disease	6.8e-05	0.000394	CcSEcCtD
Frovatriptan—Insomnia—Losartan—coronary artery disease	6.8e-05	0.000394	CcSEcCtD
Frovatriptan—Loss of consciousness—Timolol—coronary artery disease	6.78e-05	0.000393	CcSEcCtD
Frovatriptan—Decreased appetite—Furosemide—coronary artery disease	6.77e-05	0.000392	CcSEcCtD
Frovatriptan—Headache—Fenofibrate—coronary artery disease	6.75e-05	0.000391	CcSEcCtD
Frovatriptan—Paraesthesia—Losartan—coronary artery disease	6.75e-05	0.000391	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Captopril—coronary artery disease	6.75e-05	0.000391	CcSEcCtD
Frovatriptan—Vomiting—Clopidogrel—coronary artery disease	6.73e-05	0.00039	CcSEcCtD
Frovatriptan—Diarrhoea—Simvastatin—coronary artery disease	6.73e-05	0.00039	CcSEcCtD
Frovatriptan—Arthralgia—Ramipril—coronary artery disease	6.72e-05	0.000389	CcSEcCtD
Frovatriptan—Chest pain—Ramipril—coronary artery disease	6.72e-05	0.000389	CcSEcCtD
Frovatriptan—Myalgia—Ramipril—coronary artery disease	6.72e-05	0.000389	CcSEcCtD
Frovatriptan—Fatigue—Furosemide—coronary artery disease	6.71e-05	0.000389	CcSEcCtD
Frovatriptan—Tremor—Lisinopril—coronary artery disease	6.71e-05	0.000389	CcSEcCtD
Frovatriptan—Abdominal pain—Telmisartan—coronary artery disease	6.71e-05	0.000389	CcSEcCtD
Frovatriptan—Body temperature increased—Telmisartan—coronary artery disease	6.71e-05	0.000389	CcSEcCtD
Frovatriptan—Dyspnoea—Losartan—coronary artery disease	6.7e-05	0.000388	CcSEcCtD
Frovatriptan—Anxiety—Ramipril—coronary artery disease	6.7e-05	0.000388	CcSEcCtD
Frovatriptan—Vomiting—Lovastatin—coronary artery disease	6.69e-05	0.000388	CcSEcCtD
Frovatriptan—Somnolence—Losartan—coronary artery disease	6.68e-05	0.000387	CcSEcCtD
Frovatriptan—Dizziness—Eplerenone—coronary artery disease	6.68e-05	0.000387	CcSEcCtD
Frovatriptan—Asthenia—Valsartan—coronary artery disease	6.66e-05	0.000386	CcSEcCtD
Frovatriptan—Constipation—Furosemide—coronary artery disease	6.66e-05	0.000386	CcSEcCtD
Frovatriptan—Pain—Furosemide—coronary artery disease	6.66e-05	0.000386	CcSEcCtD
Frovatriptan—Hypersensitivity—Niacin—coronary artery disease	6.65e-05	0.000386	CcSEcCtD
Frovatriptan—Ill-defined disorder—Lisinopril—coronary artery disease	6.64e-05	0.000385	CcSEcCtD
Frovatriptan—Discomfort—Ramipril—coronary artery disease	6.64e-05	0.000385	CcSEcCtD
Frovatriptan—Asthenia—Olmesartan—coronary artery disease	6.63e-05	0.000384	CcSEcCtD
Frovatriptan—Headache—Clopidogrel—coronary artery disease	6.63e-05	0.000384	CcSEcCtD
Frovatriptan—Dyspepsia—Losartan—coronary artery disease	6.61e-05	0.000383	CcSEcCtD
Frovatriptan—Feeling abnormal—Perindopril—coronary artery disease	6.6e-05	0.000383	CcSEcCtD
Frovatriptan—Headache—Lovastatin—coronary artery disease	6.59e-05	0.000382	CcSEcCtD
Frovatriptan—Pruritus—Valsartan—coronary artery disease	6.57e-05	0.000381	CcSEcCtD
Frovatriptan—Dry mouth—Ramipril—coronary artery disease	6.57e-05	0.000381	CcSEcCtD
Frovatriptan—Chest pain—Timolol—coronary artery disease	6.57e-05	0.000381	CcSEcCtD
Frovatriptan—Arthralgia—Timolol—coronary artery disease	6.57e-05	0.000381	CcSEcCtD
Frovatriptan—Myalgia—Timolol—coronary artery disease	6.57e-05	0.000381	CcSEcCtD
Frovatriptan—Vomiting—Ezetimibe—coronary artery disease	6.56e-05	0.00038	CcSEcCtD
Frovatriptan—Hypersensitivity—Pravastatin—coronary artery disease	6.55e-05	0.00038	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Perindopril—coronary artery disease	6.55e-05	0.00038	CcSEcCtD
Frovatriptan—Anxiety—Timolol—coronary artery disease	6.55e-05	0.000379	CcSEcCtD
Frovatriptan—Pruritus—Olmesartan—coronary artery disease	6.54e-05	0.000379	CcSEcCtD
Frovatriptan—Decreased appetite—Losartan—coronary artery disease	6.53e-05	0.000379	CcSEcCtD
Frovatriptan—Abdominal pain—Captopril—coronary artery disease	6.52e-05	0.000378	CcSEcCtD
Frovatriptan—Body temperature increased—Captopril—coronary artery disease	6.52e-05	0.000378	CcSEcCtD
Frovatriptan—Dizziness—Simvastatin—coronary artery disease	6.5e-05	0.000377	CcSEcCtD
Frovatriptan—Confusional state—Ramipril—coronary artery disease	6.5e-05	0.000376	CcSEcCtD
Frovatriptan—Discomfort—Timolol—coronary artery disease	6.49e-05	0.000376	CcSEcCtD
Frovatriptan—Asthenia—Niacin—coronary artery disease	6.48e-05	0.000376	CcSEcCtD
Frovatriptan—Fatigue—Losartan—coronary artery disease	6.48e-05	0.000375	CcSEcCtD
Frovatriptan—Headache—Ezetimibe—coronary artery disease	6.46e-05	0.000375	CcSEcCtD
Frovatriptan—Malaise—Lisinopril—coronary artery disease	6.46e-05	0.000374	CcSEcCtD
Frovatriptan—Anaphylactic shock—Ramipril—coronary artery disease	6.44e-05	0.000373	CcSEcCtD
Frovatriptan—Vertigo—Lisinopril—coronary artery disease	6.43e-05	0.000373	CcSEcCtD
Frovatriptan—Dry mouth—Timolol—coronary artery disease	6.43e-05	0.000372	CcSEcCtD
Frovatriptan—Constipation—Losartan—coronary artery disease	6.42e-05	0.000372	CcSEcCtD
Frovatriptan—Pain—Losartan—coronary artery disease	6.42e-05	0.000372	CcSEcCtD
Frovatriptan—Syncope—Lisinopril—coronary artery disease	6.42e-05	0.000372	CcSEcCtD
Frovatriptan—Vomiting—Eplerenone—coronary artery disease	6.42e-05	0.000372	CcSEcCtD
Frovatriptan—Feeling abnormal—Furosemide—coronary artery disease	6.42e-05	0.000372	CcSEcCtD
Frovatriptan—Nausea—Fenofibrate—coronary artery disease	6.4e-05	0.000371	CcSEcCtD
Frovatriptan—Pruritus—Niacin—coronary artery disease	6.39e-05	0.00037	CcSEcCtD
Frovatriptan—Asthenia—Pravastatin—coronary artery disease	6.38e-05	0.00037	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Furosemide—coronary artery disease	6.37e-05	0.000369	CcSEcCtD
Frovatriptan—Hypersensitivity—Trandolapril—coronary artery disease	6.36e-05	0.000369	CcSEcCtD
Frovatriptan—Diarrhoea—Valsartan—coronary artery disease	6.36e-05	0.000368	CcSEcCtD
Frovatriptan—Confusional state—Timolol—coronary artery disease	6.35e-05	0.000368	CcSEcCtD
Frovatriptan—Shock—Ramipril—coronary artery disease	6.34e-05	0.000367	CcSEcCtD
Frovatriptan—Hypersensitivity—Enalapril—coronary artery disease	6.34e-05	0.000367	CcSEcCtD
Frovatriptan—Abdominal pain—Perindopril—coronary artery disease	6.33e-05	0.000367	CcSEcCtD
Frovatriptan—Body temperature increased—Perindopril—coronary artery disease	6.33e-05	0.000367	CcSEcCtD
Frovatriptan—Palpitations—Lisinopril—coronary artery disease	6.33e-05	0.000367	CcSEcCtD
Frovatriptan—Diarrhoea—Olmesartan—coronary artery disease	6.33e-05	0.000367	CcSEcCtD
Frovatriptan—Headache—Eplerenone—coronary artery disease	6.32e-05	0.000367	CcSEcCtD
Frovatriptan—Anaphylactic shock—Timolol—coronary artery disease	6.3e-05	0.000365	CcSEcCtD
Frovatriptan—Pruritus—Pravastatin—coronary artery disease	6.29e-05	0.000365	CcSEcCtD
Frovatriptan—Loss of consciousness—Lisinopril—coronary artery disease	6.29e-05	0.000365	CcSEcCtD
Frovatriptan—Nausea—Clopidogrel—coronary artery disease	6.29e-05	0.000364	CcSEcCtD
Frovatriptan—Tachycardia—Ramipril—coronary artery disease	6.29e-05	0.000364	CcSEcCtD
Frovatriptan—Vomiting—Simvastatin—coronary artery disease	6.25e-05	0.000362	CcSEcCtD
Frovatriptan—Hypersensitivity—Telmisartan—coronary artery disease	6.25e-05	0.000362	CcSEcCtD
Frovatriptan—Nausea—Lovastatin—coronary artery disease	6.25e-05	0.000362	CcSEcCtD
Frovatriptan—Hyperhidrosis—Ramipril—coronary artery disease	6.23e-05	0.000361	CcSEcCtD
Frovatriptan—Asthenia—Trandolapril—coronary artery disease	6.2e-05	0.000359	CcSEcCtD
Frovatriptan—Shock—Timolol—coronary artery disease	6.2e-05	0.000359	CcSEcCtD
Frovatriptan—Feeling abnormal—Losartan—coronary artery disease	6.19e-05	0.000359	CcSEcCtD
Frovatriptan—Diarrhoea—Niacin—coronary artery disease	6.18e-05	0.000358	CcSEcCtD
Frovatriptan—Asthenia—Enalapril—coronary artery disease	6.17e-05	0.000358	CcSEcCtD
Frovatriptan—Headache—Simvastatin—coronary artery disease	6.16e-05	0.000357	CcSEcCtD
Frovatriptan—Abdominal pain—Furosemide—coronary artery disease	6.16e-05	0.000357	CcSEcCtD
Frovatriptan—Body temperature increased—Furosemide—coronary artery disease	6.16e-05	0.000357	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Losartan—coronary artery disease	6.14e-05	0.000356	CcSEcCtD
Frovatriptan—Dizziness—Valsartan—coronary artery disease	6.14e-05	0.000356	CcSEcCtD
Frovatriptan—Anorexia—Ramipril—coronary artery disease	6.14e-05	0.000356	CcSEcCtD
Frovatriptan—Nausea—Ezetimibe—coronary artery disease	6.13e-05	0.000355	CcSEcCtD
Frovatriptan—Dizziness—Olmesartan—coronary artery disease	6.11e-05	0.000354	CcSEcCtD
Frovatriptan—Pruritus—Trandolapril—coronary artery disease	6.11e-05	0.000354	CcSEcCtD
Frovatriptan—Chest pain—Lisinopril—coronary artery disease	6.09e-05	0.000353	CcSEcCtD
Frovatriptan—Arthralgia—Lisinopril—coronary artery disease	6.09e-05	0.000353	CcSEcCtD
Frovatriptan—Myalgia—Lisinopril—coronary artery disease	6.09e-05	0.000353	CcSEcCtD
Frovatriptan—Hyperhidrosis—Timolol—coronary artery disease	6.09e-05	0.000353	CcSEcCtD
Frovatriptan—Asthenia—Telmisartan—coronary artery disease	6.09e-05	0.000353	CcSEcCtD
Frovatriptan—Pruritus—Enalapril—coronary artery disease	6.09e-05	0.000353	CcSEcCtD
Frovatriptan—Diarrhoea—Pravastatin—coronary artery disease	6.08e-05	0.000353	CcSEcCtD
Frovatriptan—Anxiety—Lisinopril—coronary artery disease	6.07e-05	0.000352	CcSEcCtD
Frovatriptan—Discomfort—Lisinopril—coronary artery disease	6.02e-05	0.000349	CcSEcCtD
Frovatriptan—Anorexia—Timolol—coronary artery disease	6e-05	0.000348	CcSEcCtD
Frovatriptan—Pruritus—Telmisartan—coronary artery disease	6e-05	0.000348	CcSEcCtD
Frovatriptan—Nausea—Eplerenone—coronary artery disease	6e-05	0.000348	CcSEcCtD
Frovatriptan—Dizziness—Niacin—coronary artery disease	5.97e-05	0.000346	CcSEcCtD
Frovatriptan—Dry mouth—Lisinopril—coronary artery disease	5.96e-05	0.000345	CcSEcCtD
Frovatriptan—Body temperature increased—Losartan—coronary artery disease	5.94e-05	0.000344	CcSEcCtD
Frovatriptan—Abdominal pain—Losartan—coronary artery disease	5.94e-05	0.000344	CcSEcCtD
Frovatriptan—Asthenia—Captopril—coronary artery disease	5.92e-05	0.000343	CcSEcCtD
Frovatriptan—Diarrhoea—Trandolapril—coronary artery disease	5.91e-05	0.000342	CcSEcCtD
Frovatriptan—Vomiting—Valsartan—coronary artery disease	5.91e-05	0.000342	CcSEcCtD
Frovatriptan—Confusional state—Lisinopril—coronary artery disease	5.89e-05	0.000341	CcSEcCtD
Frovatriptan—Diarrhoea—Enalapril—coronary artery disease	5.89e-05	0.000341	CcSEcCtD
Frovatriptan—Dizziness—Pravastatin—coronary artery disease	5.88e-05	0.000341	CcSEcCtD
Frovatriptan—Vomiting—Olmesartan—coronary artery disease	5.88e-05	0.000341	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Ramipril—coronary artery disease	5.87e-05	0.00034	CcSEcCtD
Frovatriptan—Nausea—Simvastatin—coronary artery disease	5.84e-05	0.000339	CcSEcCtD
Frovatriptan—Anaphylactic shock—Lisinopril—coronary artery disease	5.84e-05	0.000339	CcSEcCtD
Frovatriptan—Pruritus—Captopril—coronary artery disease	5.84e-05	0.000338	CcSEcCtD
Frovatriptan—Insomnia—Ramipril—coronary artery disease	5.83e-05	0.000338	CcSEcCtD
Frovatriptan—Headache—Valsartan—coronary artery disease	5.82e-05	0.000337	CcSEcCtD
Frovatriptan—Diarrhoea—Telmisartan—coronary artery disease	5.8e-05	0.000336	CcSEcCtD
Frovatriptan—Headache—Olmesartan—coronary artery disease	5.79e-05	0.000336	CcSEcCtD
Frovatriptan—Paraesthesia—Ramipril—coronary artery disease	5.78e-05	0.000335	CcSEcCtD
Frovatriptan—Shock—Lisinopril—coronary artery disease	5.75e-05	0.000333	CcSEcCtD
Frovatriptan—Asthenia—Perindopril—coronary artery disease	5.75e-05	0.000333	CcSEcCtD
Frovatriptan—Dyspnoea—Ramipril—coronary artery disease	5.74e-05	0.000333	CcSEcCtD
Frovatriptan—Vomiting—Niacin—coronary artery disease	5.74e-05	0.000333	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Timolol—coronary artery disease	5.74e-05	0.000333	CcSEcCtD
Frovatriptan—Hypersensitivity—Furosemide—coronary artery disease	5.74e-05	0.000332	CcSEcCtD
Frovatriptan—Somnolence—Ramipril—coronary artery disease	5.73e-05	0.000332	CcSEcCtD
Frovatriptan—Dizziness—Trandolapril—coronary artery disease	5.71e-05	0.000331	CcSEcCtD
Frovatriptan—Tachycardia—Lisinopril—coronary artery disease	5.7e-05	0.00033	CcSEcCtD
Frovatriptan—Insomnia—Timolol—coronary artery disease	5.7e-05	0.00033	CcSEcCtD
Frovatriptan—Dizziness—Enalapril—coronary artery disease	5.69e-05	0.00033	CcSEcCtD
Frovatriptan—Dyspepsia—Ramipril—coronary artery disease	5.67e-05	0.000329	CcSEcCtD
Frovatriptan—Pruritus—Perindopril—coronary artery disease	5.67e-05	0.000328	CcSEcCtD
Frovatriptan—Headache—Niacin—coronary artery disease	5.66e-05	0.000328	CcSEcCtD
Frovatriptan—Paraesthesia—Timolol—coronary artery disease	5.66e-05	0.000328	CcSEcCtD
Frovatriptan—Vomiting—Pravastatin—coronary artery disease	5.65e-05	0.000328	CcSEcCtD
Frovatriptan—Hyperhidrosis—Lisinopril—coronary artery disease	5.65e-05	0.000327	CcSEcCtD
Frovatriptan—Diarrhoea—Captopril—coronary artery disease	5.64e-05	0.000327	CcSEcCtD
Frovatriptan—Dyspnoea—Timolol—coronary artery disease	5.61e-05	0.000325	CcSEcCtD
Frovatriptan—Dizziness—Telmisartan—coronary artery disease	5.61e-05	0.000325	CcSEcCtD
Frovatriptan—Decreased appetite—Ramipril—coronary artery disease	5.6e-05	0.000325	CcSEcCtD
Frovatriptan—Somnolence—Timolol—coronary artery disease	5.6e-05	0.000324	CcSEcCtD
Frovatriptan—Asthenia—Furosemide—coronary artery disease	5.59e-05	0.000324	CcSEcCtD
Frovatriptan—Headache—Pravastatin—coronary artery disease	5.57e-05	0.000323	CcSEcCtD
Frovatriptan—Anorexia—Lisinopril—coronary artery disease	5.57e-05	0.000323	CcSEcCtD
Frovatriptan—Fatigue—Ramipril—coronary artery disease	5.55e-05	0.000322	CcSEcCtD
Frovatriptan—Dyspepsia—Timolol—coronary artery disease	5.54e-05	0.000321	CcSEcCtD
Frovatriptan—Hypersensitivity—Losartan—coronary artery disease	5.54e-05	0.000321	CcSEcCtD
Frovatriptan—Nausea—Valsartan—coronary artery disease	5.52e-05	0.00032	CcSEcCtD
Frovatriptan—Pruritus—Furosemide—coronary artery disease	5.51e-05	0.000319	CcSEcCtD
Frovatriptan—Constipation—Ramipril—coronary artery disease	5.51e-05	0.000319	CcSEcCtD
Frovatriptan—Nausea—Olmesartan—coronary artery disease	5.49e-05	0.000318	CcSEcCtD
Frovatriptan—Vomiting—Trandolapril—coronary artery disease	5.49e-05	0.000318	CcSEcCtD
Frovatriptan—Diarrhoea—Perindopril—coronary artery disease	5.48e-05	0.000318	CcSEcCtD
Frovatriptan—Decreased appetite—Timolol—coronary artery disease	5.47e-05	0.000317	CcSEcCtD
Frovatriptan—Vomiting—Enalapril—coronary artery disease	5.47e-05	0.000317	CcSEcCtD
Frovatriptan—Dizziness—Captopril—coronary artery disease	5.46e-05	0.000316	CcSEcCtD
Frovatriptan—Fatigue—Timolol—coronary artery disease	5.43e-05	0.000315	CcSEcCtD
Frovatriptan—Headache—Trandolapril—coronary artery disease	5.41e-05	0.000314	CcSEcCtD
Frovatriptan—Vomiting—Telmisartan—coronary artery disease	5.39e-05	0.000313	CcSEcCtD
Frovatriptan—Asthenia—Losartan—coronary artery disease	5.39e-05	0.000312	CcSEcCtD
Frovatriptan—Headache—Enalapril—coronary artery disease	5.39e-05	0.000312	CcSEcCtD
Frovatriptan—Pain—Timolol—coronary artery disease	5.39e-05	0.000312	CcSEcCtD
Frovatriptan—Nausea—Niacin—coronary artery disease	5.36e-05	0.000311	CcSEcCtD
Frovatriptan—Diarrhoea—Furosemide—coronary artery disease	5.33e-05	0.000309	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Lisinopril—coronary artery disease	5.32e-05	0.000308	CcSEcCtD
Frovatriptan—Pruritus—Losartan—coronary artery disease	5.32e-05	0.000308	CcSEcCtD
Frovatriptan—Headache—Telmisartan—coronary artery disease	5.31e-05	0.000308	CcSEcCtD
Frovatriptan—Feeling abnormal—Ramipril—coronary artery disease	5.31e-05	0.000308	CcSEcCtD
Frovatriptan—Dizziness—Perindopril—coronary artery disease	5.3e-05	0.000307	CcSEcCtD
Frovatriptan—Insomnia—Lisinopril—coronary artery disease	5.28e-05	0.000306	CcSEcCtD
Frovatriptan—Nausea—Pravastatin—coronary artery disease	5.28e-05	0.000306	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Ramipril—coronary artery disease	5.27e-05	0.000305	CcSEcCtD
Frovatriptan—Paraesthesia—Lisinopril—coronary artery disease	5.25e-05	0.000304	CcSEcCtD
Frovatriptan—Vomiting—Captopril—coronary artery disease	5.25e-05	0.000304	CcSEcCtD
Frovatriptan—Dyspnoea—Lisinopril—coronary artery disease	5.21e-05	0.000302	CcSEcCtD
Frovatriptan—Somnolence—Lisinopril—coronary artery disease	5.19e-05	0.000301	CcSEcCtD
Frovatriptan—Feeling abnormal—Timolol—coronary artery disease	5.19e-05	0.000301	CcSEcCtD
Frovatriptan—Headache—Captopril—coronary artery disease	5.17e-05	0.0003	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Timolol—coronary artery disease	5.15e-05	0.000298	CcSEcCtD
Frovatriptan—Dizziness—Furosemide—coronary artery disease	5.15e-05	0.000298	CcSEcCtD
Frovatriptan—Dyspepsia—Lisinopril—coronary artery disease	5.14e-05	0.000298	CcSEcCtD
Frovatriptan—Diarrhoea—Losartan—coronary artery disease	5.14e-05	0.000298	CcSEcCtD
Frovatriptan—Nausea—Trandolapril—coronary artery disease	5.13e-05	0.000297	CcSEcCtD
Frovatriptan—Nausea—Enalapril—coronary artery disease	5.11e-05	0.000296	CcSEcCtD
Frovatriptan—Vomiting—Perindopril—coronary artery disease	5.09e-05	0.000295	CcSEcCtD
Frovatriptan—Abdominal pain—Ramipril—coronary artery disease	5.09e-05	0.000295	CcSEcCtD
Frovatriptan—Body temperature increased—Ramipril—coronary artery disease	5.09e-05	0.000295	CcSEcCtD
Frovatriptan—Decreased appetite—Lisinopril—coronary artery disease	5.08e-05	0.000294	CcSEcCtD
Frovatriptan—Nausea—Telmisartan—coronary artery disease	5.04e-05	0.000292	CcSEcCtD
Frovatriptan—Fatigue—Lisinopril—coronary artery disease	5.04e-05	0.000292	CcSEcCtD
Frovatriptan—Headache—Perindopril—coronary artery disease	5.02e-05	0.000291	CcSEcCtD
Frovatriptan—Pain—Lisinopril—coronary artery disease	5e-05	0.00029	CcSEcCtD
Frovatriptan—Constipation—Lisinopril—coronary artery disease	5e-05	0.00029	CcSEcCtD
Frovatriptan—Body temperature increased—Timolol—coronary artery disease	4.98e-05	0.000289	CcSEcCtD
Frovatriptan—Abdominal pain—Timolol—coronary artery disease	4.98e-05	0.000289	CcSEcCtD
Frovatriptan—Dizziness—Losartan—coronary artery disease	4.97e-05	0.000288	CcSEcCtD
Frovatriptan—Vomiting—Furosemide—coronary artery disease	4.95e-05	0.000287	CcSEcCtD
Frovatriptan—Nausea—Captopril—coronary artery disease	4.9e-05	0.000284	CcSEcCtD
Frovatriptan—Headache—Furosemide—coronary artery disease	4.88e-05	0.000283	CcSEcCtD
Frovatriptan—Feeling abnormal—Lisinopril—coronary artery disease	4.81e-05	0.000279	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Lisinopril—coronary artery disease	4.78e-05	0.000277	CcSEcCtD
Frovatriptan—Vomiting—Losartan—coronary artery disease	4.78e-05	0.000277	CcSEcCtD
Frovatriptan—Nausea—Perindopril—coronary artery disease	4.76e-05	0.000276	CcSEcCtD
Frovatriptan—Hypersensitivity—Ramipril—coronary artery disease	4.75e-05	0.000275	CcSEcCtD
Frovatriptan—Headache—Losartan—coronary artery disease	4.71e-05	0.000273	CcSEcCtD
Frovatriptan—Hypersensitivity—Timolol—coronary artery disease	4.64e-05	0.000269	CcSEcCtD
Frovatriptan—Nausea—Furosemide—coronary artery disease	4.63e-05	0.000268	CcSEcCtD
Frovatriptan—Asthenia—Ramipril—coronary artery disease	4.62e-05	0.000268	CcSEcCtD
Frovatriptan—Body temperature increased—Lisinopril—coronary artery disease	4.62e-05	0.000268	CcSEcCtD
Frovatriptan—Abdominal pain—Lisinopril—coronary artery disease	4.62e-05	0.000268	CcSEcCtD
Frovatriptan—Pruritus—Ramipril—coronary artery disease	4.56e-05	0.000264	CcSEcCtD
Frovatriptan—Asthenia—Timolol—coronary artery disease	4.52e-05	0.000262	CcSEcCtD
Frovatriptan—Nausea—Losartan—coronary artery disease	4.46e-05	0.000259	CcSEcCtD
Frovatriptan—Pruritus—Timolol—coronary artery disease	4.46e-05	0.000258	CcSEcCtD
Frovatriptan—Diarrhoea—Ramipril—coronary artery disease	4.41e-05	0.000255	CcSEcCtD
Frovatriptan—Diarrhoea—Timolol—coronary artery disease	4.31e-05	0.00025	CcSEcCtD
Frovatriptan—Hypersensitivity—Lisinopril—coronary artery disease	4.3e-05	0.000249	CcSEcCtD
Frovatriptan—Dizziness—Ramipril—coronary artery disease	4.26e-05	0.000247	CcSEcCtD
Frovatriptan—Asthenia—Lisinopril—coronary artery disease	4.19e-05	0.000243	CcSEcCtD
Frovatriptan—Dizziness—Timolol—coronary artery disease	4.16e-05	0.000241	CcSEcCtD
Frovatriptan—Pruritus—Lisinopril—coronary artery disease	4.13e-05	0.00024	CcSEcCtD
Frovatriptan—Vomiting—Ramipril—coronary artery disease	4.1e-05	0.000237	CcSEcCtD
Frovatriptan—Headache—Ramipril—coronary artery disease	4.04e-05	0.000234	CcSEcCtD
Frovatriptan—Vomiting—Timolol—coronary artery disease	4e-05	0.000232	CcSEcCtD
Frovatriptan—Diarrhoea—Lisinopril—coronary artery disease	4e-05	0.000232	CcSEcCtD
Frovatriptan—Headache—Timolol—coronary artery disease	3.95e-05	0.000229	CcSEcCtD
Frovatriptan—Dizziness—Lisinopril—coronary artery disease	3.86e-05	0.000224	CcSEcCtD
Frovatriptan—Nausea—Ramipril—coronary artery disease	3.83e-05	0.000222	CcSEcCtD
Frovatriptan—Nausea—Timolol—coronary artery disease	3.74e-05	0.000217	CcSEcCtD
Frovatriptan—Vomiting—Lisinopril—coronary artery disease	3.71e-05	0.000215	CcSEcCtD
Frovatriptan—Headache—Lisinopril—coronary artery disease	3.66e-05	0.000212	CcSEcCtD
Frovatriptan—Nausea—Lisinopril—coronary artery disease	3.47e-05	0.000201	CcSEcCtD
Frovatriptan—HTR1A—Signaling Pathways—JUNB—coronary artery disease	8.81e-06	0.000134	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PLCB1—coronary artery disease	8.78e-06	0.000134	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—LPL—coronary artery disease	8.77e-06	0.000134	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOA4—coronary artery disease	8.7e-06	0.000133	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—RPS6KB1—coronary artery disease	8.69e-06	0.000132	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MEF2C—coronary artery disease	8.69e-06	0.000132	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ITGB3—coronary artery disease	8.65e-06	0.000132	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HTR7—coronary artery disease	8.6e-06	0.000131	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	8.55e-06	0.00013	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ITGB3—coronary artery disease	8.47e-06	0.000129	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CXCL8—coronary artery disease	8.44e-06	0.000129	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PDHA1—coronary artery disease	8.41e-06	0.000128	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GCLM—coronary artery disease	8.41e-06	0.000128	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PPP2CA—coronary artery disease	8.4e-06	0.000128	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CXCL8—coronary artery disease	8.27e-06	0.000126	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PRKCD—coronary artery disease	8.25e-06	0.000126	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PPP2CA—coronary artery disease	8.23e-06	0.000125	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ITGAV—coronary artery disease	8.19e-06	0.000125	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—KNG1—coronary artery disease	8.17e-06	0.000125	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	8.15e-06	0.000124	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—TXNRD1—coronary artery disease	8.14e-06	0.000124	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP11B2—coronary artery disease	8.14e-06	0.000124	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—POMC—coronary artery disease	8.14e-06	0.000124	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CREB1—coronary artery disease	8.14e-06	0.000124	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AGTR1—coronary artery disease	8.12e-06	0.000124	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PRKCD—coronary artery disease	8.08e-06	0.000123	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HTR2A—coronary artery disease	8.07e-06	0.000123	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—C3—coronary artery disease	8.06e-06	0.000123	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SLC22A3—coronary artery disease	8.02e-06	0.000122	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CCL2—coronary artery disease	7.97e-06	0.000121	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IL6R—coronary artery disease	7.94e-06	0.000121	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CXCL10—coronary artery disease	7.93e-06	0.000121	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PLG—coronary artery disease	7.91e-06	0.000121	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HTR2A—coronary artery disease	7.9e-06	0.00012	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ARNTL—coronary artery disease	7.9e-06	0.00012	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HADH—coronary artery disease	7.9e-06	0.00012	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—C3—coronary artery disease	7.89e-06	0.00012	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	7.78e-06	0.000119	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ADRB2—coronary artery disease	7.7e-06	0.000117	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HIF1A—coronary artery disease	7.69e-06	0.000117	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AGT—coronary artery disease	7.66e-06	0.000117	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PRKCE—coronary artery disease	7.6e-06	0.000116	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—JAK2—coronary artery disease	7.6e-06	0.000116	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	7.59e-06	0.000116	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SOCS1—coronary artery disease	7.59e-06	0.000116	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—S100B—coronary artery disease	7.57e-06	0.000115	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HIF1A—coronary artery disease	7.53e-06	0.000115	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—LEP—coronary artery disease	7.5e-06	0.000114	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—APOE—coronary artery disease	7.5e-06	0.000114	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AGT—coronary artery disease	7.5e-06	0.000114	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SOCS3—coronary artery disease	7.49e-06	0.000114	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOA2—coronary artery disease	7.49e-06	0.000114	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PLA2G2A—coronary artery disease	7.49e-06	0.000114	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GPX2—coronary artery disease	7.49e-06	0.000114	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—APOA1—coronary artery disease	7.42e-06	0.000113	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—KITLG—coronary artery disease	7.4e-06	0.000113	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TGFBR2—coronary artery disease	7.4e-06	0.000113	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GPX4—coronary artery disease	7.4e-06	0.000113	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SULT1A1—coronary artery disease	7.4e-06	0.000113	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ABCG5—coronary artery disease	7.4e-06	0.000113	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HK1—coronary artery disease	7.4e-06	0.000113	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	7.39e-06	0.000113	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—KDR—coronary artery disease	7.35e-06	0.000112	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—APOE—coronary artery disease	7.35e-06	0.000112	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—LEP—coronary artery disease	7.35e-06	0.000112	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HADHA—coronary artery disease	7.31e-06	0.000111	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MAPK14—coronary artery disease	7.3e-06	0.000111	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—APOA1—coronary artery disease	7.26e-06	0.000111	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—STAT5A—coronary artery disease	7.24e-06	0.00011	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MMP3—coronary artery disease	7.24e-06	0.00011	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GSTA1—coronary artery disease	7.23e-06	0.00011	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—KDR—coronary artery disease	7.2e-06	0.00011	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ESR1—coronary artery disease	7.17e-06	0.000109	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MAPK14—coronary artery disease	7.15e-06	0.000109	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—LPA—coronary artery disease	7.15e-06	0.000109	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—FN1—coronary artery disease	7.08e-06	0.000108	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—F2—coronary artery disease	7.08e-06	0.000108	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL6ST—coronary artery disease	7.05e-06	0.000107	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ESR1—coronary artery disease	7.02e-06	0.000107	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APOB—coronary artery disease	6.99e-06	0.000107	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NFKBIA—coronary artery disease	6.99e-06	0.000107	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CXCL8—coronary artery disease	6.93e-06	0.000106	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—F2—coronary artery disease	6.93e-06	0.000106	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—FN1—coronary artery disease	6.93e-06	0.000106	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PLCB3—coronary artery disease	6.92e-06	0.000106	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL6ST—coronary artery disease	6.9e-06	0.000105	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—JAK2—coronary artery disease	6.9e-06	0.000105	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—EDN1—coronary artery disease	6.88e-06	0.000105	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOA5—coronary artery disease	6.85e-06	0.000104	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NFKBIA—coronary artery disease	6.85e-06	0.000104	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCL5—coronary artery disease	6.83e-06	0.000104	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—KIT—coronary artery disease	6.77e-06	0.000103	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CSF2—coronary artery disease	6.73e-06	0.000103	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FGF1—coronary artery disease	6.73e-06	0.000103	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—P4HB—coronary artery disease	6.72e-06	0.000102	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—LPL—coronary artery disease	6.68e-06	0.000102	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	6.66e-06	0.000101	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—KIT—coronary artery disease	6.63e-06	0.000101	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—RPS6KB1—coronary artery disease	6.62e-06	0.000101	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MEF2C—coronary artery disease	6.62e-06	0.000101	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PLA2G1B—coronary artery disease	6.6e-06	0.000101	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	6.52e-06	9.94e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—GSK3B—coronary artery disease	6.5e-06	9.91e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ITGB3—coronary artery disease	6.45e-06	9.83e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	6.45e-06	9.83e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—POMC—coronary artery disease	6.45e-06	9.83e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CREB1—coronary artery disease	6.45e-06	9.83e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—GSK3B—coronary artery disease	6.36e-06	9.7e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CREB1—coronary artery disease	6.31e-06	9.62e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—POMC—coronary artery disease	6.31e-06	9.62e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCL2—coronary artery disease	6.31e-06	9.62e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CXCL8—coronary artery disease	6.3e-06	9.6e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL6R—coronary artery disease	6.29e-06	9.59e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PPP2CA—coronary artery disease	6.27e-06	9.55e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—VCAN—coronary artery disease	6.22e-06	9.48e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IGF1—coronary artery disease	6.2e-06	9.45e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCL2—coronary artery disease	6.18e-06	9.42e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—MAPK1—coronary artery disease	6.17e-06	9.41e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ALDOA—coronary artery disease	6.17e-06	9.41e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL6R—coronary artery disease	6.16e-06	9.39e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PRKCD—coronary artery disease	6.15e-06	9.38e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IGF1—coronary artery disease	6.07e-06	9.26e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—MAPK1—coronary artery disease	6.04e-06	9.21e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HTR2A—coronary artery disease	6.02e-06	9.18e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—C3—coronary artery disease	6.01e-06	9.17e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—DCN—coronary artery disease	5.99e-06	9.13e-05	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—PIK3CA—coronary artery disease	5.9e-06	8.99e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—SERPINE1—coronary artery disease	5.89e-06	8.98e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ALDH2—coronary artery disease	5.83e-06	8.88e-05	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—PIK3CA—coronary artery disease	5.77e-06	8.8e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—SERPINE1—coronary artery disease	5.77e-06	8.79e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HIF1A—coronary artery disease	5.73e-06	8.74e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AGT—coronary artery disease	5.71e-06	8.71e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—FGF2—coronary artery disease	5.7e-06	8.69e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	5.68e-06	8.66e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HBA1—coronary artery disease	5.68e-06	8.66e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—LIPC—coronary artery disease	5.68e-06	8.66e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	5.68e-06	8.66e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP2C19—coronary artery disease	5.68e-06	8.66e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOC3—coronary artery disease	5.64e-06	8.6e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NOS3—coronary artery disease	5.62e-06	8.57e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—LDLR—coronary artery disease	5.61e-06	8.55e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	5.6e-06	8.54e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—LEP—coronary artery disease	5.6e-06	8.53e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APOE—coronary artery disease	5.6e-06	8.53e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—FGF2—coronary artery disease	5.58e-06	8.51e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SLC9A1—coronary artery disease	5.54e-06	8.45e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GSTT1—coronary artery disease	5.54e-06	8.45e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APOA1—coronary artery disease	5.53e-06	8.44e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NOS3—coronary artery disease	5.51e-06	8.39e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—KDR—coronary artery disease	5.48e-06	8.36e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CETP—coronary artery disease	5.48e-06	8.35e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GCLC—coronary artery disease	5.48e-06	8.35e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—JAK2—coronary artery disease	5.46e-06	8.33e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MAPK14—coronary artery disease	5.45e-06	8.31e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—SDC1—coronary artery disease	5.42e-06	8.26e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—PIK3CA—coronary artery disease	5.36e-06	8.16e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—JAK2—coronary artery disease	5.35e-06	8.16e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ESR1—coronary artery disease	5.34e-06	8.15e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—F2—coronary artery disease	5.28e-06	8.05e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FN1—coronary artery disease	5.28e-06	8.05e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL6ST—coronary artery disease	5.26e-06	8.02e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—PIK3CA—coronary artery disease	5.24e-06	7.99e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NFKBIA—coronary artery disease	5.22e-06	7.95e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PSMA6—coronary artery disease	5.12e-06	7.8e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PSMB5—coronary artery disease	5.12e-06	7.8e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	5.11e-06	7.79e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—KIT—coronary artery disease	5.05e-06	7.7e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CTGF—coronary artery disease	5e-06	7.62e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CXCL8—coronary artery disease	4.99e-06	7.6e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HMGCR—coronary artery disease	4.95e-06	7.55e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GOT2—coronary artery disease	4.95e-06	7.55e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CXCL8—coronary artery disease	4.88e-06	7.44e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GSK3B—coronary artery disease	4.85e-06	7.39e-05	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—AKT1—coronary artery disease	4.82e-06	7.34e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—POMC—coronary artery disease	4.81e-06	7.33e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CREB1—coronary artery disease	4.81e-06	7.33e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CASP3—coronary artery disease	4.77e-06	7.28e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—IL6—coronary artery disease	4.74e-06	7.23e-05	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—AKT1—coronary artery disease	4.72e-06	7.19e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCL2—coronary artery disease	4.71e-06	7.17e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL6R—coronary artery disease	4.69e-06	7.15e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CASP3—coronary artery disease	4.67e-06	7.13e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCND1—coronary artery disease	4.65e-06	7.08e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—IL6—coronary artery disease	4.64e-06	7.08e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IGF1—coronary artery disease	4.63e-06	7.05e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—MAPK1—coronary artery disease	4.6e-06	7.02e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PLCB1—coronary artery disease	4.56e-06	6.95e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCND1—coronary artery disease	4.55e-06	6.94e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MMP9—coronary artery disease	4.51e-06	6.88e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	4.47e-06	6.81e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MMP9—coronary artery disease	4.42e-06	6.73e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ABCA1—coronary artery disease	4.42e-06	6.73e-05	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PIK3CA—coronary artery disease	4.4e-06	6.71e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—SERPINE1—coronary artery disease	4.39e-06	6.7e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—AKT1—coronary artery disease	4.38e-06	6.67e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—AKT1—coronary artery disease	4.28e-06	6.53e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GOT1—coronary artery disease	4.28e-06	6.52e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GGT1—coronary artery disease	4.28e-06	6.52e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FGF2—coronary artery disease	4.25e-06	6.48e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NOS3—coronary artery disease	4.19e-06	6.39e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—JAK2—coronary artery disease	4.08e-06	6.21e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—VEGFA—coronary artery disease	4.05e-06	6.17e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PIK3CA—coronary artery disease	3.99e-06	6.09e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—VEGFA—coronary artery disease	3.97e-06	6.05e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GSTP1—coronary artery disease	3.84e-06	5.86e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	3.81e-06	5.8e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HMOX1—coronary artery disease	3.79e-06	5.78e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CAT—coronary artery disease	3.74e-06	5.7e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CXCL8—coronary artery disease	3.72e-06	5.67e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TGFB1—coronary artery disease	3.72e-06	5.67e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MAPK1—coronary artery disease	3.65e-06	5.56e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TGFB1—coronary artery disease	3.64e-06	5.55e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOB—coronary artery disease	3.63e-06	5.53e-05	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—AKT1—coronary artery disease	3.59e-06	5.48e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MAPK1—coronary artery disease	3.57e-06	5.44e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CASP3—coronary artery disease	3.56e-06	5.43e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IL6—coronary artery disease	3.54e-06	5.39e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GSTM1—coronary artery disease	3.53e-06	5.38e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCND1—coronary artery disease	3.47e-06	5.28e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—LPL—coronary artery disease	3.47e-06	5.28e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GPX1—coronary artery disease	3.38e-06	5.15e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MMP9—coronary artery disease	3.36e-06	5.13e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CD36—coronary artery disease	3.29e-06	5.02e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	3.26e-06	4.97e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PPP2CA—coronary artery disease	3.25e-06	4.96e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PIK3CA—coronary artery disease	3.16e-06	4.82e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—MTHFR—coronary artery disease	3.12e-06	4.76e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PIK3CA—coronary artery disease	3.1e-06	4.72e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	3.02e-06	4.61e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—AGT—coronary artery disease	2.96e-06	4.52e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOE—coronary artery disease	2.9e-06	4.43e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOA1—coronary artery disease	2.87e-06	4.38e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL6—coronary artery disease	2.8e-06	4.27e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	2.77e-06	4.23e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.75e-06	4.19e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL6—coronary artery disease	2.74e-06	4.18e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	2.72e-06	4.15e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—AKT1—coronary artery disease	2.58e-06	3.94e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—AKT1—coronary artery disease	2.53e-06	3.86e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PPARG—coronary artery disease	2.53e-06	3.86e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—POMC—coronary artery disease	2.5e-06	3.8e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	2.36e-06	3.6e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ALB—coronary artery disease	2.27e-06	3.47e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NOS3—coronary artery disease	2.18e-06	3.32e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL6—coronary artery disease	2.09e-06	3.19e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PTGS2—coronary artery disease	1.99e-06	3.03e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—AKT1—coronary artery disease	1.93e-06	2.94e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PIK3CA—coronary artery disease	1.22e-06	1.87e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—AKT1—coronary artery disease	1e-06	1.52e-05	CbGpPWpGaD
